These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10426561)
1. Common multiple interactions of tricyclic anti-depressants and orphenadrine with liver microsomal cytochrome P450 enzymes of the rat. Roos PH Xenobiotica; 1999 Jun; 29(6):629-40. PubMed ID: 10426561 [TBL] [Abstract][Full Text] [Related]
2. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants. Murray M; Field SL Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495 [TBL] [Abstract][Full Text] [Related]
3. Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes. Roos PH; Mahnke A Biochem Pharmacol; 1996 Jul; 52(1):73-84. PubMed ID: 8678911 [TBL] [Abstract][Full Text] [Related]
4. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline. Murray M Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Reidy GF; Mehta I; Murray M Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477 [TBL] [Abstract][Full Text] [Related]
6. Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes. Yamazaki H; Shimada T Xenobiotica; 1998 Oct; 28(10):995-1004. PubMed ID: 9849646 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites. McNeil CM; Murray M Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263 [TBL] [Abstract][Full Text] [Related]
8. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Guo Z; Raeissi S; White RB; Stevens JC Drug Metab Dispos; 1997 Mar; 25(3):390-3. PubMed ID: 9172960 [TBL] [Abstract][Full Text] [Related]
9. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070 [TBL] [Abstract][Full Text] [Related]
10. Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liver. Silvia M; Vincenzo L; Arturo M; Giovanni GP Biochem Pharmacol; 1994 Aug; 48(4):717-26. PubMed ID: 8080444 [TBL] [Abstract][Full Text] [Related]
11. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105 [TBL] [Abstract][Full Text] [Related]
13. N-Dealkylation of chlorimipramine and chlorpromazine by rat liver microsomal cytochrome P450 isoenzymes. Valoti M; Frosini M; Palmi M; De Matteis F; Sgaragli G J Pharm Pharmacol; 1998 Sep; 50(9):1005-11. PubMed ID: 9811161 [TBL] [Abstract][Full Text] [Related]
14. Interaction of 2,4,4'-trichloro-2'-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver. Hanioka N; Omae E; Nishimura T; Jinno H; Onodera S; Yoda R; Ando M Chemosphere; 1996 Jul; 33(2):265-76. PubMed ID: 8696774 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of cytochromes P450 2B in rat liver by orphenadrine. Murray M; Fiala-Beer E; Sutton D Br J Pharmacol; 2003 Jun; 139(4):787-96. PubMed ID: 12813002 [TBL] [Abstract][Full Text] [Related]
16. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
18. Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Bensoussan C; Delaforge M; Mansuy D Biochem Pharmacol; 1995 Mar; 49(5):591-602. PubMed ID: 7887973 [TBL] [Abstract][Full Text] [Related]
19. P450 enzyme CYP2B catalyzes the detoxification of diisopropyl fluorophosphate. Laaksonen M; Kaliste-Korhonen E; Kärenlampi S; Hänninen O Chem Biol Interact; 1995 Mar; 94(3):197-213. PubMed ID: 7820884 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]